Frank Thomas
2019
In 2019, Frank Thomas earned a total compensation of $1.5M as President & COO at Orchard Therapeutics plc.
Compensation breakdown
Non-Equity Incentive Plan | $250,000 |
---|---|
Option Awards | $802,520 |
Salary | $430,043 |
Other | $11,200 |
Total | $1,493,763 |
Thomas received $802.5K in option awards, accounting for 54% of the total pay in 2019.
Thomas also received $250K in non-equity incentive plan, $430K in salary and $11.2K in other compensation.
Rankings
In 2019, Frank Thomas' compensation ranked 7,334th out of 13,971 executives tracked by ExecPay. In other words, Thomas earned more than 47.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,334 out of 13,971 | 48th |
Division Manufacturing | 2,828 out of 5,701 | 50th |
Major group Chemicals And Allied Products | 1,057 out of 2,200 | 52nd |
Industry group Drugs | 900 out of 1,886 | 52nd |
Industry Biological Products, Except Diagnostic Substances | 207 out of 389 | 47th |
Source: SEC filing on April 28, 2021.
Thomas' colleagues
We found two more compensation records of executives who worked with Frank Thomas at Orchard Therapeutics plc in 2019.